MREO
Mereo BioPharma
MREO
MREO
70 hedge funds and large institutions have $25.8M invested in Mereo BioPharma in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
37% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 35
87% less capital invested
Capital invested by funds: $205M → $25.8M (-$179M)
Holders
70
Holding in Top 10
–
Calls
$1.68M
Puts
$902K
Top Buyers
| 1 | +$19.3M | |
| 2 | +$15M | |
| 3 | +$8.29M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$2.57M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$2.44M |
Top Sellers
| 1 | -$33.6M | |
| 2 | -$19.4M | |
| 3 | -$16M | |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$11.4M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$9.42M |